The encouragement of innovation at the regional level has been the subject of a series of EU initiatives, but there is, as yet, no overarching framework that provides clear, effective and widely accepted guidance for policy-makers. We identify some of the limitations facing innovation policy in...

We compare some of the policies that have been attempted in Europe (UK/Scotland) and Israel over the past fifteen years to elaborate a new Systems Evolutionary (SE) framework for rethinking VC policy and related ITP. We argue that this perspective is useful for both real world (‘positive’)...

This paper focuses on the patterns of venture capital (VC) investment in dedicated biotech firms (DBFs) in the therapeutic and diagnostic sectors (bio-healthcare). We use a database of 655 UK bio-healthcare deals to map the geographical flows of VC investment and measure the co-location of...

Despite many attempts to develop high-impact venture capital (VC) policies, most VC markets in Europe are still underdeveloped. Many of these policies were based on ‘traditional’ (Rosiello et al, 2009) VC policy involving a mix of monetary incentives and institutional changes. In this...